[Federal Register: March 18, 2003 (Volume 68, Number 52)]
[Notices]
[Page 12911-12912]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18mr03-59]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Renewals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
renewal of certain FDA advisory committees by the Commissioner of Food
and Drugs (the Commissioner). The Commissioner has determined that it
is in the public interest to renew the charters of the committees
listed in the following table for an additional 2 years beyond charter
expiration date. The new charters will be in effect until the dates of
expiration listed in the following table. This notice is issued under
the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-
463 (5 U.S.C. app. 2)).
DATES: Authority for these committees will expire on the dates
indicated in the following table unless the Commissioner formally
determines that renewal is in the public interest.
------------------------------------------------------------------------
Name of committee Date of expiration
------------------------------------------------------------------------
Science Board to the Food and Drug June 26, 2004
Administration
Allergenic Products Advisory July 9, 2004
Committee
Cardiovascular Drugs Advisory August 27, 2004
Committee
Endocrinologic and Metabolic Drugs August 27, 2004
Advisory Committee
Oncologic Drugs Advisory Committee September 1, 2004
Anti-Infective Drugs Advisory October 7, 2004
Committee
Dermatologic and Ophthalmic Drugs October 7, 2004
Advisory Committee
Biological Response Modifiers October 28, 2004
Advisory Committee
Technical Electronic Product December 24, 2004
Radiation Safety Standards
Committee
Antiviral Drugs Advisory Committee February 15, 2005
------------------------------------------------------------------------
[[Page 12912]]
FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee
Oversight and Management Staff (HF-4), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
Dated: March 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-6397 Filed 3-17-03; 8:45 am]
BILLING CODE 4160-01-S